Latest Content

FDA Approves Companion Diagnostic Test for Hernexeos in NSCLC

August 11th 2025, 5:14pm

By Ryan Scott

Article

The FDA has approved the Oncomine Dx Target Test to identify patients with HER2-mutant non-small cell lung cancer who are eligible for Hernexeos treatment.

Patients and Caregivers Aim to Raise Funds for Myeloma Research

August 11th 2025, 4:00pm

By Ryan Scott

Article

Ashley Dieks and Dr. Saad Z. Usmani discussed how bicycling may help patients cope with the emotional and physical challenges of their myeloma diagnosis.

How Community Support Networks Shaped My Journey Through Cancer Care

August 11th 2025, 3:00pm

By Patti McGee

Article

August is World Cancer Support month, and a time to honor the quiet strength of caregivers and the communities that lift them up.

New Guidelines Shift Donor Selection for Patients With Blood Cancer

August 11th 2025, 1:00pm

By Dr. Antonio M. Jimenez

Video

Advancements in transplant medicine for blood cancers have prompted updates in how doctors choose donors for allogeneic hematopoietic cell transplants.

Gut Bacteria May Help Predict Heart Risks in Breast Cancer Treatment

August 10th 2025, 6:00pm

By Spencer Feldman

Article

Certain gut bacteria were linked to higher risk of heart damage in older patients with breast cancer, suggesting a possible role for preventative probiotics.

Side Effects to Expect While on Datroway Treatment for Lung Cancer

August 10th 2025, 2:00pm

By Ryan Scott

Article

Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according to Dr. Jacob Sands.

Navigating EHE: Connecting with Experts and Support

August 9th 2025, 6:00pm

By Gina Mauro

Article

Support and research for epithelioid hemangioendothelioma are growing, with the EHE Foundation helping connect patients to expert care and resources.

Immunoglobulin Replacement Not Associated With Fewer Infections in CLL

August 9th 2025, 2:00pm

By Alex Biese

Article

Among patients with chronic lymphocytic leukemia, immunoglobulin replacement therapy is not associated with a reduced risk of serious infections.

New Clinical Trials Launch as Cancer Treatment Studies Advance

August 8th 2025, 9:00pm

By Spencer Feldman

Article

Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid tumor, and urothelial cancers.

Using Social Media to Amplify the Patient Voice and Advocacy

August 8th 2025, 8:00pm

By Clara Cirks

Video

Clara Cirks is a stage 4 lung cancer patient who uses platforms like TikTok and Instagram to amplify her voice and raise awareness about patient advocacy

FDA Approves Hernexeos for Non-Squamous Non-Small Cell Lung Cancer

August 8th 2025, 5:49pm

By Alex Biese

Article

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

A Moment of Kindness I’ll Never Forget During Cancer Treatment

August 8th 2025, 5:00pm

By Laura Yeager

Article

During World Cancer Support Month, I’m remembering a moment in 2012 a group of teachers — especially Mrs. Reed — lifted me up with unexpected kindness.

Incidence of Early-Onset Liver Cancer in Younger Patients Decreasing

August 8th 2025, 4:00pm

By Ryan Scott

Article

The incidence of hepatocellular carcinoma has risen between 2010 and 2019; however, for people under 50 years of age, the proportion of cases has declined.

Epkinly Combo Reduces Risk of Progression or Death in Follicular Lymphoma

August 8th 2025, 3:00pm

By Alex Biese

Article

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

How Biomarkers May Help Guide Kidney Cancer Treatment Earlier

August 8th 2025, 1:00pm

By Dr. Wenxin (Vincent) Xu

Video

Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.